A professional society for glomerular disease experts, founded 2022. President @Tobias_B_Huber Español @ISGD_la 🦋 bsky.app/profile/isgd.bsky.s…
Massachusetts/worldwide
- Tweets 2,042
- Following 921
- Followers 2,393
- Likes 2,345
New GN in 10 🚨
Primary or secondary FSGS? Picking the right lane changes everything for your patient—from avoiding unnecessary immunosuppression to optimizing hemodynamics.
Faculty hosts @kdjhaveri and @koyaljainMD break down the clinical essentials on this GN in 10 "Board Review Bonus" episode. 🧵👇
1
3
11
485
In this bite-sized clinical review: • Telltale signs that distinguish secondary FSGS from primary disease • Biopsy clues that reveal hyperfiltration stress vs. viral or drug triggers • How to build an effective kidney-protective regimen focused on reducing glomerular workload
🎧 Catch the full breakdown to sharpen your board prep and clinical instincts: share.transistor.fm/s/38a601…
#NephTwitter #GlomTwitter #MedEd #KidneyHealth #GNin10
93
Centers of Excellence: Two new publications. One shared vision. ISGD x GlomCon!
Centers of Excellence in Glomerular Disease aim to unite comprehensive patient care, cutting-edge research, clinical trials, education, and equitable access to innovative therapies worldwide. With two complementary consensus papers now published in Kidney International and Kidney International Reports, we have reached an important milestone toward this shared goal.
Tobias B. Huber, ISGD’s Founding President, commented, “Together we are turning scientific excellence into global impact, connecting research, innovation, and clinical care for the benefit of patients worldwide.” Ali Poyan Mehr, GlomCon’s Founding President, shared, “Patients everywhere deserve access to expert glomerular care.” These publications lay the groundwork to bring this vision to life together. By joining forces under one unified Centers of Excellence program, we can set shared standards that advance excellence and improve access worldwide.
GlomCon and ISGD are now working together to establish a unified global certification program, with final criteria and next steps coming soon!
Thank you to all authors, contributors, and partners who helped us reach this milestone. Exciting times ahead!
Read the papers here:
sciencedirect.com/science/ar…
sciencedirect.com/science/ar…
7
15
680
ISGD announces the launch of GD-Kids, a global initiative advancing pediatric glomerular disease research, clinical trials, and collaboration to improve care for children worldwide.
Read the press release: is-gd.org/en/news-from-isgd/…
#GDKids #ISGD
1
2
7
479
📷 Last week’s ISGD Pediatric Clinical Trials Bootcamp at the IPNA-ESPN Junior Master Class in Bordeaux! With 100+ in the room and 100+ online, we are thrilled to see the global community come together. 📷📷 1/3
1
1
348
Our mission? Preparing young nephrologists to join the clinical trial workforce. 📷 It was incredible to connect early-career professionals with senior faculty and industry partners to drive the future of kidney medicine. 2/3
1
193
Huge thanks to our amazing faculty for their time and expertise! 📷Next stop: Clinical Trials Bootcamp in Mar del Plata, Argentina! 📷 Stay tuned. 3/3
#ISGD #ClinicalTrials #Nephrology #GlomerularDisease #ESPN2026 #PediatricNephrology #CTB #nephtwitter
1
2
245
Lower serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA-glomerulonephritis
academic.oup.com/ckj/advance…
6
21
1,455
International Society of Glomerular Disease retweeted
Please see our review on unmet needs in the management of lupus nephritis - aiming for a balanced view
academic.oup.com/ndt/advance…
1
17
58
1,957
⏰ Time is running out!
Registration for the ISGD Clinical Trials Summit 2026 closes October 1.
Join leading experts from across the clinical trials and glomerular disease field for important conversations shaping the future of clinical research.
Meet the industry experts. Connect with leaders. Be part of what’s next.
📅 November 13–15, 2026 | Galveston, TX
🔗 Register now: is-gd.org/2026-cts
#ISGD #ClinicalTrials #GlomerularDisease #KidneyResearch #Nephrology
4
5
492
Clinical trial bootcamp training @ ALANEPE Congress 2026. ISGD is proud to host our Clinical Trials Bootcamp on Oct. 28 in Mar del Plata, Argentina. Looking forward to provide this training to over 120 Latam peds nephs!
Learn more: is-gd.org/ctbalanepe
#ISGD #ALANEPE2026 #nephtwitter
3
9
628
Don't Wait. Submit Now.
Late-Breaking Abstracts Open Through October 1.
🌊 Your research belongs in Galveston!
The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts!
📅 Opens Sept. 1
⏰ Deadline Oct. 1
Share your latest research with leaders in glomerular disease.
🔬 Submit: CTS 2026 Late Breaker Info
@Barbara58932871 @Tobias_B_Huber @ISGDtweets
5
6
818
🚀 The future of pediatric clinical trials starts here!
ISGD Pediatric Clinical Trials Bootcamp is coming to ESPN 2026. Practical training, mentorship & networking to prepare the next generation of trial investigators.
👉 Register now! congressespn.org/ipna-espn-j…
#ISGD #ESPN2026 #ClinicalTrials
2
4
442
International Society of Glomerular Disease retweeted
Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy | New England Journal of Medicine nejm.org/doi/full/10.1056/NE… @NEJM @fervenzaf
10
42
4,204
International Society of Glomerular Disease retweeted
Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS. @h4amer @NDTsocial
dx.doi.org/10.1093/ndt/gfag1…
academic.oup.com/ndt/article…
4
7
1,044
ISGD meets in Philadelphia.A meaningful visit to the Hospital of the University of Pennsylvania brought together colleagues, clinical perspectives, and important conversations about the future of glomerular medicine.Connecting. Learning. Advancing. Together.
@Barb @Tobi @ISGD
#ISGD #GlomerularMedicine #GlomerularDisease #Nephrology #KidneyResearch
5
343
Six more experts. Six more perspectives. One big goal. 🔬 Meet more of the incredible speakers joining the ISGD Clinical Trials Summit in Galveston, Nov. 13–15! 🌎 Clinical trials. Collaboration. The future of glomerular medicine. 👉 is-gd.org/2026-CTS
2
3
365
🌊 Your research belongs in Galveston!
The ISGD Clinical Trials Summit 2026 is calling for Late Breaking Abstracts!
📅 Opens Sept. 1
⏰ Deadline Oct. 1
Share your latest research with leaders in glomerular disease.
🔬 Submit: CTS 2026 Late Breaker Info
@Barbara58932871 @Tobias_B_Huber @ISGDtweets
Made with AI
2
2
1,495